4
Changes in Ownership
Taysha Gene Therapies, Inc. Filed Acc 0001209191-22-007126
Director bought 201,602 shares at an average $7.80 ($1,571,810)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Manning Paul B Director | 2022-02-02 | Purchase | +58,000 | $7.77 | $450,660 | 92,202 | D |
| Manning Paul B Director | 2022-02-02 | Purchase | +45,000 | $7.77 | $349,650 | 2,065,102 | I |
| Manning Paul B Director | 2022-02-02 | Purchase | +22,000 | $7.77 | $170,940 | 22,000 | I |
| Manning Paul B Director | 2022-02-03 | Purchase | +50,000 | $7.84 | $392,000 | 142,202 | D |
| Manning Paul B Director | 2022-02-03 | Purchase | +26,602 | $7.84 | $208,560 | 2,091,704 | I |
| Open-market purchases · 201,602 sh · avg $7.80 · $1,571,810 | |||||||
Loading xslF345X03/doc4.xml…